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Abstract
Background: Infection with Plasmodium falciparum during pregnancy contributes substantially to the disease
burden in both mothers and offspring. Placental malaria may lead to intrauterine growth restriction or preterm
delivery resulting in low birth weight (LBW), which, in general, is associated with increased infant morbidity and
mortality. However, little is known about the possible direct impact of the specific disease processes occurring in
PM on longer term outcomes such as subsequent retarded growth development independent of LBW.
Methods: In an existing West-African cohort, 783 healthy infants with a birth weight of at least 2,000 g were
followed up during their first year of life. The aim of the study was to investigate if Plasmodium falciparum
infection of the placenta, assessed by placental histology, has an impact on several anthropometric parameters,
measured at birth and after three, six and 12 months using generalized estimating equations models adjusting for
moderate low birth weight.
Results: Independent of LBW, first to third born infants who were exposed to either past, chronic or acute
placental malaria during pregnancy had significantly lower weight-for-age (-0.43, 95% CI: -0.80;-0.07), weight-for-
length (-0.47, 95% CI: -0.84; -0.10) and BMI-for-age z-scores (-0.57, 95% CI: -0.84; -0.10) compared to infants born to
mothers who were not diagnosed with placental malaria (p = 0.019, 0.013, and 0.012, respectively). Interestingly,
the longitudinal data on histology-based diagnosis of PM also document a sharp decline of PM prevalence in the
Sukuta cohort from 16.5% in 2002 to 5.4% in 2004.
Conclusions: It was demonstrated that PM has a negative impact on the infant’s subsequent weight development
that is independent of LBW, suggesting that the longer term effects of PM have been underestimated, even in
areas where malaria transmission is declining.
Background
Despite the availability of appropriate tools to control
malaria and recently strengthened efforts to employ
them efficiently [1], the latest estimates still consider 3.3
billion people at risk of acquiring malaria each year. In
2006, 247 million malaria cases were reported, causing
almost one million deaths [2]. Approximately 50 million
pregnant women are at risk of malaria, more than 50%
of whom live in areas of sub-Saharan Africa with intense
transmission of Plasmodium falciparum[3]. In these
areas at least one in four pregnant women (all parities)
has evidence of malaria infection at delivery defined as
either peripheral malaria or placental malaria (PM) [4,5].
Where transmission is low, peripheral and placental
parasitaemia prevalence was estimated as 13.7% and
6.7%, respectively [6].
The deleterious effects of malaria in pregnancy on the
morbidity and mortality of fetuses and newborns are
well recognized. The impact of PM on the mother
depends on the level of acquired immunity and is more
severe in non-immune women. In highly endemic areas,
where women can be assumed to be partially immune,
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the frequency and severity of the infection is highest in
primigravidae. The main effects of malaria in preg-
nancy on birth outcomes are thought to be mediated
by maternal anaemia [7,8] and placental insufficiency
[9-13]. Both factors have been suggested to act
together to cause either intrauterine growth restriction
(IUGR) [14] or preterm delivery [15,16], leading to low
birth weight (LBW) [17-19]. A number of studies have
demonstrated a firm association between PM and
LBW [4,5,13,20], and in general, LBW itself is known
to be highly associated with infant morbidity and mor-
tality [21,22]. Likewise, in children born to mothers
with PM, the associated LBW has been suggested as a
major risk factor for neonatal and infant mortality
[23-25]. It has been estimated that PM causes 167,000-
967,000 cases of LBW in Africa, associated with
62,000-363,000 newborn deaths each year [4,26]. How-
ever, it has been emphasized that these infant deaths
are not due to the impact of LBW alone, but to the
general disease processes which have resulted in LBW
[27]. In addition, PM has been associated with a two-
fold increase in risk of stillbirth [28], and may put the
foetus at increased risk of congenital cytomogalovirus
infections [29]. While the immediate consequences of
PM and LBW on neonatal and infant morbidity and
mortality have been studied extensively, comparatively
little is known about the possible long-term impact of
PM on the subsequent development of the child. To
date only one study has shown that 12 month old
infants exposed to maternal malaria at delivery (pla-
cental or peripheral) were lighter and thinner than
children who were not exposed to PM [30], even after
controlling for low birth weight.
Since LBW in itself, regardless of the underlying pro-
cesses, has been associated with inhibited growth,
impaired cognitive development, and increased inci-
dence of chronic diseases later in life [31], it is difficult
to study potential direct effects of PM on the subse-
quent development of the child that are independent of
the effects caused by the associated LBW. This study
addressed whether PM has an additional or ‘indepen-
dent’ effect on growth development, apart from the
known effects of PM following the causal pathway
(exposure to PM → LBW → incomplete catch-up growth
[30] → growth retardation). The direct impact of PM on
the child’s subsequent growth development during the
first year of life was investigated by using data from an
ongoing Gambian cohort study, which was specifically
designed to enroll healthy babies, excluding those with a
birth weight below 2,000 g. This study design and sub-
sequent analysis adjusting for moderate low birth weight
(2,000 g - 2,499 g) offered the unique opportunity to
study the impact of PM independent of LBW or overt
co-morbidity.
Methods
Study participants and recruitment
Data were collected from children born between January
2002 and July 2005 as part of an ongoing open cohort
study at the maternity ward of the Health Centre in
Sukuta, a semi-urban Gambian village 30 km south of
the capital Banjul, where malaria transmission varies
considerably between season, with highest incidence
during the wet season and immediately afterwards
(’malaria season’: August - December). The main study,
as well as the analysis strategy of the data presented
here, was approved by the Joint Gambian Government/
MRC Ethics Committee. The newborns delivered at the
maternity ward were enrolled after informed consent of
the mother was obtained. The purpose of the main
cohort was to study immune responses of infants to vac-
cines and infections. Since overt morbidity, as well as
risk factors associated with LBW, are known to increase
susceptibility to infectious diseases and thus bias any
immunological responses [32-35] only healthy singleton
children were eligible for recruitment into the cohort.
Newborns below a birth weight of 2,000 g were
excluded from the study.
A survey among Gambian pregnant women in 2000-
01 [36] estimated the prevalence of HIV to be 1.0% (CI:
0.9-2.4%) in Serekunda, an urban settlement approxi-
mately 10 km from Sukuta. Based on this estimate, HIV
+ cases are unlikely to have significantly impacted on
the results of this study, and following ethical guidance
HIV testing was not performed.
Study Design
Demographic, anthropometric and clinical data from
783 mother/child pairs were used to investigate the
association of maternal PM and height and weight in
the first year of life of the offspring. Basic demographic
and socio-economic data, such as, ethnicity, age, and
parity of the mother, education of the parents and, as a
measure for overcrowding, number of persons sleeping
in one bedroom, as well as information on malaria treat-
ment and bednet use were collected in face-to-face
interviews by trained fieldworkers using questionnaires
shortly after birth. Infants were followed up monthly
over a 12-month period for morbidity and anthropo-
metric measurements. At each follow up visit trained
nurses recorded the number of illness episodes during
the previous month reported by the mother or guardian
of the child and administered vaccines according to the
recommended Gambian Expanded Programme of
Immunization schedule. Maternal height and weight
were recorded six months after delivery.
PM status was defined by placental histology. After
birth a placental biopsy was taken and embedded in par-
affin and stained for histological analysis of PM status
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[29]. Cases were classified according to Ismail [37] as
active infection (presence of infected red blood cells in
the intervillous space of the placenta) and past infection
(no parasites, but haemozoin deposition in macro-
phages). Active infection was further subdivided into
acute infections (only parasites and minimal haemozoin
deposition) and chronic infections (parasites and signifi-
cant haemozoin deposition).
Childrens’ weight and length measurements at three,
six and 12 months of age (+/- 15 days) were used to cal-
culate four age/gender-standardized indicators: ‘weight-
for-age’ (wfa), ‘length-for-age’ (lfa), ‘weight-for-length’
(wfl) and ‘body-mass-index-for-age’ (BMIfa) based on
the WHO “Child Growth Standards, 2006” using the
Stata macro ‘igrowup.ado’[38].
Statistical methods
All data were double entered into an Access database
(Microsoft), validated and checked for range and consis-
tency. Prior to investigating if PM is associated with
infant’s size and nutritional status, univariable analyses
were used to assess whether known PM risk factors
(young maternal age, low parity, low socio-economic
status, no bednet use, and seasonality of malaria trans-
mission) [6] were present in this study population. A
logistic regression model was fitted including all risk
factors with p-values less than 0.2 in univariable analy-
sis, which were kept in the model at a significance level
p ≤ 0.05. The final model including parity, PM season
and year, and duration of schooling of the mother was
used to calculate adjusted ORs and corresponding p-
values of being PM+ comparing the individual exposure
groups to a specified baseline group.
The hypothesis that exposure to PM would be asso-
ciated with lower values for anthropometric indicators
was tested at each of the three time points three, six
and 12 months using univariable analyses first. Addi-
tional mother and child characteristics such as maternal
age, height, BMI, parity, duration of schooling, living in
crowded housing conditions as well as gender of the
child, moderate low birth weight of 2,000 g - 2,499 g,
current age of the child, month and year of birth, and
whether the child was born in the ‘hungry’ season (dur-
ing the months with intensive rain fall from July to
October) [39,40] were investigated as risk factors for
reduced indicators. Univariable analyses were conducted
to examine the association of each factor with the four
anthropometric indicators described above at three, six
and 12 months of age.
Cross-sectional times series models using generalized
estimating equations (GEE) to fit the parameters of the
models with exchangeable correlation structure were
then constructed for each anthropometric indicator. The
final models account for multiple weight and length
measurements at three, six and 12 months of age and
confounding factors such as sex, moderate low birth
weight of 2,000 g - 2.499 g, infant’s age, birth month
and year, parity and education (duration of schooling) of
the mother. An interaction term was included for PM
exposure status of the child and parity to investigate if
the association of PM and size of the infant varied
between parity groups. Since the association of PM and
the growth indicators wfa, wfl and BMIfa was not signif-
icantly different for two or three pregnancies, but for
more than four pregnancies compared to the first preg-
nancy, data was split into two groups according to 1-3
and 4 and more pregnancies. Maternal age and living in
crowded housing conditions lacked a significant associa-
tion with z-scores and was therefore not included in the
final models. Mother’s height and BMI were not consid-
ered, since 61% of the data were missing. No difference
was seen for anthropometric measurements taken dur-
ing or after the ‘hungry’ season; thus “hungry season”
was not included in the models. The resulting models
were used to assess the effect of PM exposure on each
anthropometric indicator independent of birth weight.
Whether maternal exposure to PM was associated
with being underweight, wasted or stunted (wfa, wfl or
lfa z-scores<-2, respectively) was investigated using
logistic regression. Odds ratios for the group of wasted
or underweight infants and a second group of stunted
infants were calculated choosing all the remaining well-
nourished infants as the baseline group.
Results
Baseline characteristics of the study population
Available data from 783 mother/child pairs, collected
between January 2002 and July 2005 were analysed. In
each year, with the exception of 2005, a comparable
number of babies were enrolled and genders were
equally distributed with 54.2% (SD 0.5%) being male.
Mean birth weight and length were 3,045 g (SD 449 g)
and 48.5 cm (SD 2.2 cm), respectively. 80 babies (10.3%)
had a birth weight of 2,000 g - 2,499 g. Mean maternal
age was 25.6 years (SD 5.5 years). 74 (9.5%) placentas
were P. falciparum infected; 37/74 (50%) of which were
classified as active infection, which was further sub-
divided into 21/74 (28.4%) acute and 16/74 (21.6%)
chronic infections. The remaining 50% were classified as
past infected. Further maternal and child characteristics
are summarized in Table 1.
Factors associated with PM
The cohort was assessed for known risk factors for PM
[6]. As has been described previously, PM was signifi-
cantly associated with first pregnancy and lower socio-
economic status of the mother. However, in this cohort
initial univariable analysis did not reveal a significant
association of maternal age, BMI, ethnicity, treatment
for malaria and bednet use with PM (Additional file 1).
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In the presented study, maternal anaemia, a conse-
quence of PM known to be associated with LBW
[13,17,41-44] was not associated with PM and newborns
in the PM+ group were not significantly lighter than new-
borns in the PM- group (Additional file 2). During the one
year follow up infants in both comparison groups suffered
a similar number of all-cause morbidity episodes.
Lower z-scores for anthropometric indicators for children
born to PM+ mothers independent of LBW
To assess the impact of PM status at birth on growth
development during the first year of life, 1,491 (PM+:
137, PM-: 1354) z-scores for each of four anthropo-
metric indicators (wfa, lfa, BMIfa, and wfl) were ana-
lysed (528 at three months, 510 at six months and 453
at 12 months of age). At all time points mean z-scores
for wfa, lfa, and BMIfa were significantly lower than
zero (mean range across age: wfa: -0.59 to -0.26; lfa:
-0.67 to -0.27; and BMIfa: -0.29 to -0.10), indicating that
Gambian children recruited in the cohort were lighter,
smaller, and had lower values for BMI than children of
the world standard population with same sex and age
characteristics (p < 0.0001). Mean wfl z-scores were sig-
nificantly lower than zero at six months (-0.05, p =
0.038) and 12 months (-0.36, p < 0.0001), but not at
three months (0.06, p = 0.565).
Using univariable analysis comparing children born to
PM+ mothers with those born to PM- mothers, infants
exposed to PM had at least borderline significantly
lower mean z-scores for all four anthropometric indica-
tors at 12 months (Figure 1). Mean differences ranged
from 0.29 z-scores (CI: 0.18; 0.40) to 0.60 z-scores (CI:
0.48; 0.70). The mean differences in z-scores between 12
and three months were not significantly different
between PM+ and PM- groups (wfa: p = 0.738, lfa: p =
0.790, BMIfa: p = 0.9995, and wfl: p = 0.668).
Longitudinal analysis using generalized estimating
equations (GEE) accounting for multiple measurements
for infants at different time points, and for risk factors
for low anthropometric indicators such as parity and
duration of maternal education, moderate low birth
weight (2,000 g - 2.499 g), gender, month and year of
birth, revealed that wfa, BMIfa and wfl z-scores were
significantly associated with maternal PM status for first
to third borns. However, PM exposure had no effect on
lfa z-scores (Table 2).
Figure 1, representing the raw data for each of the
four anthropometric indicators at the three time points
for PM+ and PM- groups, implies that the impact of
PM on anthropometric indicators might be stronger
within the third age group than within the first two
groups. The tests for an interaction of PM and age for
the final GEE models adjusting for confounding factors
such as gender, duration of maternal education and par-
ity, moderate low birth weight, birth month and year of
the infant were not significant. The presented data do
therefore not support the hypothesis of an effect grada-
tion with increasing age.
At the age of three, six and 12 months 20.1%, 9.6%,
and 22.2% of the infants in the PM+ group were either
wasted, underweight or stunted compared to 14.2%,
13.1%, and 17.0% in the PM- group, respectively. The
odds for wasting or being underweight were 2.4 and 3.1
times higher in the PM exposed group at the age of
three and 12 months respectively, but did not reach sig-
nificance (p = 0.095 for both). Infants of the PM+
Table 1 Baseline characteristics of the study population
for 2002-05
Maternal characteristics,
N = 783
No (%)
Age of the mother
Age <20 99 (12.6)
Age 20-24 252 (32.2)
Age 25-29 219 (28.0)
Age ≥30 179 (22.9)
Unknown 34 (4.3)
Number of pregnancies
First 153 (19.5)
Second 173 (22.1)
Third 123 (15.7)
Fourth 100 (12.8)
Fifth 81 (10.4)
Sixth or more 153 (19.5)
Mother’s ethnic group
Mandinka 426 (54.4)
Fula 95 (12.1)
Wolof 87 (11.1)
Jola 78 (10.0)
Serere 37 (4.7)
Serahula 22 (2.8)
Manjago 11 (1.4)
Other 27 (3.5)
Duration of education of the mother
0-4 years 199 (25.4)
5 and more years 403 (51.5)
Unknown 181 (23.1)
Placental malaria
Not infected 709 (90.6)
Acute 21 (2.7)
Chronic 16 (2.0)
Past 37 (4.7)
Baby’s characteristics, N = 783
Year of birth
2002 164 (21.0)
2003 218 (27.8)
2004 277 (35.4)
2005 (January - July) 124 (15.8)
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groups were not significantly more likely to be stunted
compared to infants of the PM- group within any age
group.
Steady decline in PM prevalence from January 2002 to
July 2005
As shown in Figure 2, the percentage of mothers with
PM seen at the Sukuta Health Centre decreased signifi-
cantly from 16.5% (27/164) in 2002, to 5.4% (15/277) in
2004 (ptrend < 0.0001). For 2005, data were available for
the non transmission season only (January to July), but
the risk of PM during the non transmission season was
significantly lower in 2004 and 2005 than in 2002 (odds
ratio (OR)2004 0.42, CI (0.18; 0.95), p = 0.038, OR2005
0.08, CI (0.02; 0.37), p-value = 0.001, respectively), with
a highly significant trend (ptrend < 0.001).
Influence of seasonal malaria transmission on PM
prevalence
The majority of PM cases (55/74, 76%) were diagnosed
during the months of October to March (OR 2.85, CI
(1.62; 5.03), p < 0.0001). Mothers delivering during the
malaria transmission period (August to December) were
more likely to be diagnosed with acute PM compared to
mothers delivering during the non-transmission period
from January to July (OR 3.00, CI (1.16; 7.79), p =
0.024; ptrend < 0.011 [AOR 3.00, CI (1.14; 7.94), p* =
0.026, ptrend = 0.014]). By contrast, seasonality of malaria
Figure 1 Anthropometric indicators of infants who were either placental malaria exposed or unexposed during pregnancy. Median,
inter quartile range, and range (minimum to maximum value) of four anthropometric indicators weight-for-age, length-for-age, BMI-for-age and
weight-for-length are presented for infants born to placental malaria positive (open boxes) and placental malaria negative mothers (black boxes)
at the age of three, six, and 12 months.
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transmission had no effect on chronic infection preva-
lence (OR 1.12, CI (0.42; 3.04), p = 0.82). A delayed sea-
sonal effect could be observed for past infections in that
they were significantly more likely to be diagnosed in
the last three months of the malaria transmission season
or thereafter through to March of the following year
(OR 2.97, CI (1.33; 6.66), p < 0.008; [adjusted OR
(AOR) 3.97, CI (1.67; 9.40), adjusted p-value (p*) =
0.005]) (Figure 3).
Discussion
By taking advantage of a cohort study specifically
designed to recruit healthy babies, and subsequent ana-
lysis adjusting for moderate low birth weight, the direct
impact of PM on the infant’s size during the first year
of life independent from LBW-associated effects was
examined. The main aim of this study was to investigate
if babies who were exposed to PM showed a signifi-
cantly different growth pattern during infancy compared
to babies who were not exposed to PM, when the babies
in both groups had a similar weight distribution at birth.
The finding that the birth weights of the PM+ and PM-
groups were not significantly different suggests that we
successfully enrolled babies of similar birth weight dis-
tribution in both groups. Therefore any PM effects on
subsequent growth could not be accounted for by a
lower starting birth weight in the PM+ group.
This study shows that first to third born infants of PM
+ mothers were significantly lighter, thinner and had
lower BMIfa z-scores compared to infants of PM-
mothers. The analysis comprised all PM exposed infants
disregarding the histological subgroup of PM. Since
severity of pathological changes within the placenta,
gestational age at infection or duration of infection are
closely associated with PM subgroups, it is likely that
the association of growth development might be differ-
ent within the subgroups past, chronic and active PM.
Unfortunately this study wasn’t sufficiently powered to
enable performance of such subgroup analyses.
PM exposed infants were 2.4 times more likely to be
wasted at the age of three months and 3.1 times more
likely to be underweight at the age of 12 months than
infants born to PM- mothers. Since the described effect
is independent of LBW, this suggests that the overall
Table 2 Association of placental malaria* and anthropo-
metric indicators of infants
Anthropometric
indicator
z-scores difference
[(PM+) - (PM-)]**
CI 95% p-value
Weight-for-age
1-3 pregnancies -0.43 -0.80; -0.07 0.019
≥4 pregnancies 0.02 -0.44; 0.48 0.930
Weight-for-length
1-3 pregnancies -0.47 -0.84; -0.10 0.013
≥4 pregnancies 0.03 -0.44; 0.50 0.903
BMI-for-age
1-3 pregnancies -0.57 -0.84; -0.10 0.012
≥4 pregnancies 0.03 -0.43; 0.50 0.889
Length-for-age
All parities -0.11 -0.37; 0.15 0.405
* Total of past, chronic and active placental malaria (PM)
**Difference in z-scores of PM exposed and unexposed infants (z-score (PM+)
- z-score (PM-))
The table presents the results of the Generalized Estimating Equations models
investigating a possible association of exposure to maternal PM during
pregnancy and anthropometric indicators (weight-for-age (wfa), weight-for-
length (wfl), BMI-for-age (BMIfa) and length-for-age (lfa)) of the infants. 1,488
(PM+:135, PM-:1353) z-scores for each of four anthropometric indicators were
included in the GEE model (1-3 pregnancies: 833 observations (PM+:86, PM-
:747); ≥4 pregnancies: 655 observations (PM+: 49, PM-: 606)). The models
account for multiple weight and length measurements at three, six and 12
months of age and confounding factors such as moderate low birth weight
below (2,000 g - 2,499 g), infant’s age, sex, birth month and year, and
duration of maternal education. Significant interactions between PM infection
and parity were fitted for the first three anthropometric indicators (wfa, wfl,
and BMIfa), but not for lfa.
Figure 2 Decline in placental malaria prevalence during 2002-
2004. The percentage of P. falciparum infected placentas (assessed
by histology) among all women giving birth is shown per annum,
ptrend < 0.0001.
Figure 3 Seasonality of placental malaria. The percentage of
acute (open bars), chronic (dotted bars) and past (black bars)
placental malaria infections is shown over time. From January 2002
till December 2004 21/72 (29.2%) were classified as acute, 16/72
(22.2%) as chronic, and 35/72 (48.6%) as past infection.
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burden of PM may have been underestimated. In addi-
tion, it should be borne in mind that irrespective of PM
status, and despite the exclusion of babies with low
birth weight (≤ 2,000 g), infants recruited in the Sukuta
cohort were significantly lighter, smaller, and had lower
values for BMI than children of the world standard
population. Any additional negative effect on nutritional
status such as that we described here may therefore
become even more relevant for these children.
Overall infants had significantly lower z-scores at 12
months compared to z-scores at three month of age, an
effect which might be explained by a change in feeding
practice and increased mobility of the infant and there-
fore higher exposure to pathogens. A limitation of the
study is that information on gestational age and breast
feeding practices, an important correlate of postnatal
growth, was not collected. However, most mothers
exclusively breast feed for 6 months, and thereafter con-
tinue breast feeding alongside giving solid food past the
age of 1 year. The possibility that the described associa-
tion of PM and infant’s growth development has been
confounded by maternal height and BMI cannot be
excluded. However, among those mothers with available
data for height and BMI (39%), median values were not
significantly different between PM+ and PM- mothers.
The presented findings imply that the increased risk
for poorer weight gain independent of LBW applies to
the first to third born infants of PM+ mothers, but not
for ≥ fourth born children. Gravidity effects have been
described in studies analyzing for the effect of PM on
subsequent susceptibility to malaria in early life [34,45].
These gravidity effects have been attributed to the
higher malaria antigen load and greater degree of pla-
cental inflammation that is thought to occur in the
lower gravidity states, since these woman have lower
anti-chondroitin sulfate A antibody levels and thus less
immunity against PM [45]. However gravidity related
altered susceptibility to malaria itself is unlikely to
account for the delayed growth in the PM exposed
group in this study, since diagnosed malaria was rare in
the 1st year of life in this population. Therefore other
immunological mechanisms need to be considered.
The inflammatory effects of PM are generally thought to
bias the neonatal immune system towards a Th1 inflam-
matory response [46], and this immune bias could lead to
more severe inflammation in response to other infectious
diseases encountered in the 1st year of life. Several groups
have proposed that immunological tolerance or regulatory
T cells might also be primed by PM, which might then
result in altered susceptibility to malaria, and also have a
non-specific immunosuppressive role [47,48]. Indeed, sev-
eral studies have since shown that malaria-specific Tregs
are primed by PM [49-52]. It has also been shown that
non-specific Tregs can be induced by PM, possibly due to
priming of innate responses by malaria antigens via pat-
tern recognition receptors such as the toll like receptors
[52]. Indeed, TLR mutations have been shown to play an
important role in the outcome of pregnancy associated
malaria, and in particular TLR-4 and -9 mutations are
associated with increased risk of low birth weight in term
infants [53]. Altered innate immunity in early life and
increased non-specific Tregs could certainly enhance sus-
ceptibility to other pathogens and antigens and therefore
result in poorer growth development. The number of all
cause morbidity episodes between PM exposed and PM
not exposed infants were not significantly different in the
presented study, although numbers were small and the
severity and duration of illness was not assessed.
One further mechanism as to how PM might influ-
ence early life development independent of birth weight
is its effects on leptin levels. Leptin regulates appetite
and metabolism, and during pregnancy the placenta acts
as an additional source of leptin [54]. PM has been
shown to cause a disruption in the relationship between
leptin and birth weight [55], and although it is not
known whether leptin responsiveness is later restored,
an early lack of leptin responsiveness could certainly
contribute to poor growth in PM+ children. Clearly the
effect of PM on subsequent immunity in early life is a
research an area of great interest, and the precise immu-
nological effects have yet to be fully elucidated.
Several publications report a marked decline of malaria
prevalence over the recent years in sub-Saharan Africa
[56-60]. For The Gambia, a retrospective record based
analysis of malaria incidence spanning from 1999 to 2007
carried out in a region that included the catchment area
of Sukuta Health Centre, observed a marked decline in
the annual number of admissions and deaths attributed
to malaria, particularly since 2003 [61]. Malaria preva-
lence surveys carried out at the end of the transmission
season 2007/8 document unprecedentedly low levels of
malaria in the Gambia and Guinea Bissau [62]. The pre-
sented data on histology-based diagnosis of PM support
this further, documenting a decline in malaria incidence.
While in 2002 the study site could have been classified as
a high transmission region, based on a PM prevalence of
16.5%, PM prevalence decreased markedly to 5.4% in
2004, indicative of low levels of malaria transmission [6].
Since yearly rainfall data for the Gambia, including the
study area Sukuta, do not indicate a significant reduction
in average rainfall during the study period, it is rather
unlikely that changes in rainfall could account for the
observed steep decline in PM prevalence.
A steady increase in bednet coverage in The Gambia
for children <5 years from 42% in 2000 to 63% in 2005
[63] may have contributed to this decline, although in
this study bednet usage was comparable among PM+
and PM- mothers. Intermittent preventative treatment
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for malaria in pregnancy with sulphadoxine-pyrimetha-
mine (Fansidar®) was introduced at Sukuta HC antenatal
clinic in 2005 and therefore cannot account for the
decline in PM.
Earlier reports suggest a delayed seasonal effect on PM
prevalence in areas of seasonal transmission [13], which
is confirmed by the presented data. Using placental his-
tology it was demonstrated that the vast majority of PM
cases detected in the non transmission season are attri-
butable to past placental infections, reaching a peak in
January to March. As expected, those cases classified as
acute PM closely follow the seasonal transmission pat-
tern, while no significant seasonal variation could be
observed in the incidence of chronic PM.
A previous study in a semi-urban area of The Gambia
showed socio-economic factors, but not education, to be
significantly associated with increased risk for P. falci-
parum infection [64]. In particular, poor and crowded
housing conditions were identified as risk factors. While
crowding was also associated with PM in the presented
dataset, poorer maternal education (duration of school-
ing) was identified as an additional risk factor for PM.
Adequate maternal education may therefore help redu-
cing the burden of PM.
Conclusions
In summary, it was shown that PM exposure during
pregnancy has a negative impact on the infant’s growth
development for first to third born infants that is inde-
pendent of, but additional to, the well-documented dele-
terious effects of LBW associated with PM
[4,5,20,23,24,65] This suggests that the burden of PM
on the infant’s development may have been underesti-
mated, which points out the paramount importance of
control strategies for malaria in pregnancy. The main
findings of this study, the additional impact of PM on
development of infants and the decline in PM over
time, illustrate the importance of epidemiological data
in designing control measures and determining treat-
ment priorities.
Additional file 1: Risk factors for placental malaria for mothers
delivering at maternity ward of Sukuta Health Centre from January
2002 to July 2005, multivariable analysis for 2002-04. The table
provided represents the results of the statistical analysis assessing the risk
factors for placental malaria (PM).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1475-2875-9-16-
S1.DOC ]
Additional file 2: Association of placental malaria with maternal
anaemia and baby’s characteristics at birth. The table in this file
shows the results of the statistical analysis investigating if maternal and
baby’s outcome characteristics at birth were different between PM+ and
PM- groups.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1475-2875-9-16-
S2.DOC ]
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